Advertisement
Person › Details
Andreas Weiler (Lonza (Group))
Weiler, Andreas (Lonza 201505 Head of Emerging Technology, Lonza Pharma&Biotech)
Organisation | Lonza (Group) | |
Product | contract manufacturing (biologicals) | |
Product 2 | cell therapy | |
Record changed: 2019-06-09 |
Advertisement
More documents for Andreas Weiler
- [1] TxCell S.A.. (5/31/18). "Press Release: TxCell Names Lonza as Its CAR-Treg Cellular Product Manufacturer". Valbonne & Basel....
- [2] Lonza Group Ltd.. (4/10/18). "Press Release: Lonza Opens World’s Largest Dedicated Cell and Gene Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA)". Pearland, Greater Houston, TX....
- [3] Lonza Group Ltd.. (5/30/17). "Press Relase: Lonza Acquires Cell and Gene Contract Manufacturer PharmaCell". Basel....
- [4] Lonza Group Ltd.. (2/16/17). "Press Release: Lonza and Selecta Biosciences Announce Manufacturing Agreement for Anc80-AAV-Based Gene Therapy for Treatment of Methylmalonic Acidemia". Basel & Watertown, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top